A SPECIALIST UK BUSINESS MANAGEMENT CONSULTANCY

OPERATING ON THE GLOBAL STAGE
YE23 turnover of £720,000 with an EBITDA of £135,000.
Turnover of £830,000 in the first 10 months of YE24, with an EBITDA of £198,000.
Cash generating and debt-free.
An ideal opportunity for international businesses to establish a base within the UK or for expansion of the UK operation.
Primary services are concentrated on the Life Science / Pharmaceutical Sector targeting divestments, mergers, acquisitions, transformation and change, internal restructuring and programme delivery.
Excellent relationships with large global corporate clients, including Approved Supplier Listings in sectors where access is not easily available, including the Finance Sector.
Scope for growth and expansion within existing customer base and/or through new markets and clients.
Offered as a fully relocatable opportunity.
The management team are willing to provide a mutually agreed handover period, if required.
A flexible and dynamic workforce of trusted partners, consultants and contractors to deliver services.
Offered for sale to facilitate retirement plans.
Offers invited.